1. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. Issue 12 (December 2022) Authors: Datoo, Mehreen S; Natama, Hamtandi Magloire; Somé, Athanase; Bellamy, Duncan; Traoré, Ousmane; Rouamba, Toussaint; Tahita, Marc Christian; Ido, N Félix André; Yameogo, Prisca; Valia, Daniel; Millogo, Aida; Ouedraogo, Florence; Soma, Rachidatou; Sawadogo, Seydou; Sorgho, Faizatou; Derra, Karim; Ro... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Issue 10287 (15th May 2021) Authors: Datoo, Mehreen S; Natama, Magloire H; Somé, Athanase; Traoré, Ousmane; Rouamba, Toussaint; Bellamy, Duncan; Yameogo, Prisca; Valia, Daniel; Tegneri, Moubarak; Ouedraogo, Florence; Soma, Rachidatou; Sawadogo, Seydou; Sorgho, Faizatou; Derra, Karim; Rouamba, Eli; Orindi, Benedict; Ramos Lopez, Fern... Journal: Lancet Issue: Volume 397:Issue 10287(2021) Page Start: 1809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mass administration of azithromycin reduces childhood mortality in Niger. Issue 5 (8th September 2020) Authors: Murphy, Sarah; Datoo, Mehreen S Journal: Archives of disease in childhood Issue: Volume 106:Issue 5(2021) Page Start: 320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗